Hope Elizabeth Uronis, MD

Associate Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 435 Seeley G. Mudd Building, Box 2823, Durham, NC 27710
Phone (919) 681-3480
In Their Words

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Duke University, 2005 - 2007
  • Chief Medical Resident -Duke Hospital, Medicine, Duke University, 2004 - 2005
  • Fellow in Hematology-Oncology, Medicine, Duke University, 2003 - 2004
  • Medical Resident, Medicine, Duke University, 2000 - 2003
  • M.D., State University of New York at Buffalo, 2000

Publications

Sohal, DPS, Kennedy, EB, Khorana, A, Copur, MS, Crane, CH, Garrido-Laguna, I, Krishnamurthi, S, Moravek, C, O'Reilly, EM, Philip, PA, Ramanathan, RK, Ruggiero, JT, Shah, MA, Urba, S, Uronis, HE, Lau, MW, and Laheru, D. "Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 36, no. 24 (August 2018): 2545-2556.

PMID
29791286
Full Text

Vlahovic, G, Meadows, KL, Hatch, AJ, Jia, J, Nixon, AB, Uronis, HE, Morse, MA, Selim, MA, Crawford, J, Riedel, RF, Zafar, SY, Howard, LA, O'Neill, M, Meadows, JJ, Haley, ST, Arrowood, CC, Rushing, C, Pang, H, and Hurwitz, HI. "A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer." The Oncologist 23, no. 7 (July 2018): 782-790.

PMID
29572245
Full Text

Kelly, K, Johnson, ML, Mahalingam, D, Liu, SV, Uronis, HE, and Wu, C. "A phase 2A open-label, multicenter trial of the safety and efficacy of LYC-55716, a first-in-class oral, small-molecule ROR gamma agonist to treat select solid tumors.": AMER SOC CLINICAL ONCOLOGY, May 20, 2018.

Full Text

Catenacci, DVT, Park, H, Uronis, HE, Kang, Y-K, Lacy, J, and Enzinger, PC. "Margetuximab (M) plus pembrolizumab (P) in ERBB2-amplified PD-L1+gastroesophageal adenocarcinoma (GEA) post trastuzumab (T).": AMER SOC CLINICAL ONCOLOGY, May 20, 2018.

Full Text

Jia, J, Niedzwiecki, D, Uronis, HE, Morse, M, Zafar, Y, and Hsu, SD. "A phase I/II trial of cabozantinib (C) with or without panitumumab (P) in patients (pts) with RAS wild-type (WT) metastatic colorectal cancer (mCRC): Clinical outcomes in pts with MET amplification (amp) detected in blood.": AMER SOC CLINICAL ONCOLOGY, May 20, 2018.

Full Text

Porter, LS, Keefe, FJ, Baucom, DH, Olsen, M, Zafar, SY, and Uronis, H. "A randomized pilot trial of a videoconference couples communication intervention for advanced GI cancer." Psycho Oncology 26, no. 7 (July 2017): 1027-1035.

PMID
28691761
Full Text

Spiegel, D, Palta, M, and Uronis, H. "Role of Chemotherapy and Radiation Therapy in the Management of Gastric Adenocarcinoma." The Surgical Clinics of North America 97, no. 2 (April 2017): 421-435. (Review)

PMID
28325195
Full Text

Riedel, RF, Meadows, KL, Lee, PH, Morse, MA, Uronis, HE, Blobe, GC, George, DJ, Crawford, J, Niedzwiecki, D, Rushing, CN, Arrowood, CC, and Hurwitz, HI. "Phase I study of pazopanib plus TH-302 in advanced solid tumors." Cancer Chemotherapy and Pharmacology 79, no. 3 (March 2017): 611-619.

PMID
28238078
Full Text

Porter, LS, FIsh, L, Uronis, HE, Zafar, Y, and Steinhauser, KE. "The elephant in the room: Facilitating conversations about advanced cancer between patients and their spouses." October 9, 2016.

Full Text

Susko, M, Lee, J, Salama, J, Thomas, S, Uronis, H, Hsu, D, Migaly, J, Willett, C, Czito, B, and Palta, M. "The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer." Annals of surgical oncology 23, no. 11 (October 2016): 3609-3615.

PMID
27169769
Full Text

Pages